◀ Back to CREBBP
CREBBP — PPARD
Pathways - manually collected, often from reviews:
-
BioCarta wnt signaling pathway:
beta-catenin/TCF/CtBP1/CBP/TLE1/SMAD4 complex (CTNNB1-TCF1-CTBP1-CREBBP-TLE1-SMAD4)
→
PPAR-delta (PPARD)
(transcription, activates)
-
BioCarta wnt signaling pathway:
CtBP1/CBP/TCF/TLE1 complex (CTBP1-CREBBP-TCF1-TLE1)
→
PPAR-delta (PPARD)
(transcription, inhibits)
-
NCI Pathway Database Presenilin action in Notch and Wnt signaling:
beta catenin/TCF1/CtBP/CBP/TLE1/AES/SMAD4 complex (CTNNB1-HNF1A-CTBP1-CREBBP-TLE1-AES)
→
PPAR delta (PPARD)
(transcription, activates)
-
NCI Pathway Database Presenilin action in Notch and Wnt signaling:
CtBP/CBP/TCF1/TLE1/AES complex (CTBP1-CREBBP-HNF1A-TLE1-AES)
→
PPAR delta (PPARD)
(transcription, inhibits)
Text-mined interactions from Literome
Berger et al., J Biol Chem 1999
(Diabetes Mellitus, Experimental) :
We conclude that : 1 ) synthetic non-thiazolidinediones can serve as ligands of PPARgamma and PPARdelta ; 2 ) ligand dependent activation of
PPARdelta involves an apparent conformational change and association of the receptor ligand binding domain with
CREB binding protein ; 3 ) PPARgamma activation ( but not PPARdelta or PPARalpha activation ) is sufficient to potentiate preadipocyte differentiation ; 4 ) non-thiazolidinedione PPARgamma agonists improve hyperglycemia and hypertriglyceridemia in vivo ; 5 ) although PPARalpha activation is sufficient to affect triglyceride metabolism, PPARdelta activation does not appear to modulate glucose or triglyceride levels
Sue et al., Am J Physiol Cell Physiol 2009
:
Surprisingly, other than altering the CRE binding protein ( CREB ), BPS mediated
PPARdelta activation
increased nuclear localization of the
CREB binding protein (CBP) , a coactivator, which was further confirmed by chromatin immunoprecipitation